WCM
BIIB icon

Weik Capital Management’s Biogen BIIB Stock Holding History

Weik Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,350
Closed -$313K – 94
2024
Q2 		$313K Sell
1,350
-90
-6% -$19.6K 0.13% 84
2024
Q1 		$311K Buy
1,440
+180
+14% +$42.2K 0.13% 86
2023
Q4 		$326K Sell
1,260
-275
-18% -$67.5K 0.15% 79
2023
Q3 		$395K Buy
+1,535
New +$411K 0.19% 72

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weik Capital Management's BIIB Position: Q3 2024 in Review

Weik Capital Management sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,350 shares — an estimated $313K sold.

Weik Capital Management first reported a position in BIIB in Q3 2023 and held it in 4 quarters. The position peaked at $395K in Q3 2023. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Weik Capital Management reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Weik Capital Management sold 1,350 Biogen shares in Q3 2024, an estimated $313K.
  • Weik Capital Management first reported a position in Biogen in Q3 2023 and held it in 4 quarters.
  • Weik Capital Management's Biogen position peaked at $395K in Q3 2023.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Weik Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.